Cargando…

Code status transitions in patients with high-risk acute myeloid leukemia

Patients with high-risk acute myeloid leukemia (AML) often experience intensive medical care at the end of life (EOL), including high rates of hospitalizations and intensive care unit (ICU) admissions. Despite this, studies examining code status transitions are lacking. We conducted a mixed-methods...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abrams, Hannah R., Nipp, Ryan D., Traeger, Lara, Lavoie, Mitchell W., Reynolds, Matthew J., Ufere, Nneka N., Wang, Annie C., Boateng, Kofi, LeBlanc, Thomas W., El-Jawahri, Areej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Health Services and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327548/ https://www.ncbi.nlm.nih.gov/pubmed/35537113 http://dx.doi.org/10.1182/bloodadvances.2022007009

Ejemplares similares

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
por: Bhatt, Sunil, et al.
Publicado: (2022)

What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients
por: Barata, Anna, et al.
Publicado: (2023)

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
por: Johnson, P. Connor, et al.
Publicado: (2023)

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes
por: LoCastro, Marissa, et al.
Publicado: (2021)

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma
por: O’Donnell, Elizabeth K., et al.
Publicado: (2022)

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
por: Shallis, Rory M., et al.
Publicado: (2023)

Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
por: Fingrut, Warren B., et al.
Publicado: (2022)

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology
por: Wood, William A., et al.
Publicado: (2021)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2023)

Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
por: Hantel, Andrew, et al.
Publicado: (2021)

Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
por: Lee, Alfred Ian, et al.
Publicado: (2022)

Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis
por: Luan, Danny, et al.
Publicado: (2022)

Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer
por: Nipp, Ryan D., et al.
Publicado: (2016)

Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia
por: El‐Jawahri, Areej, et al.
Publicado: (2018)

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
por: Singh, Ashima, et al.
Publicado: (2021)

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
por: Stojkov, Igor, et al.
Publicado: (2021)

How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
por: Nieuwlaat, Robby, et al.
Publicado: (2021)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States
por: Kuczmarski, Thomas M., et al.
Publicado: (2022)

Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
por: Delforge, Michel, et al.
Publicado: (2022)

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
por: Wang, Rong, et al.
Publicado: (2022)

Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
por: Bankar, Aniket, et al.
Publicado: (2023)

Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
por: Lee, Thomas D., et al.
Publicado: (2023)

Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
por: Chase, Matthew L., et al.
Publicado: (2023)

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2023)

Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
por: Kelley, Rachel A., et al.
Publicado: (2022)

Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease
por: Zeno, Rachel N., et al.
Publicado: (2022)

Influence of participant and reviewer characteristics in application scores for a hematology research training program
por: Vesely, Sara K., et al.
Publicado: (2023)

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy
por: Cronin, Robert M., et al.
Publicado: (2022)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
por: Tam, Constantine, et al.
Publicado: (2023)

Coping strategies in patients with acute myeloid leukemia
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Code Status Documentation Availability and Accuracy Among Emergency Patients with End-stage Disease
por: Russell, Evan, et al.
Publicado: (2021)

Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence
por: Robbins-Welty, Gregg A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_50skh6urf2j9uv4f67a7bd8fbk